## UNH: UnitedHealth Group Incorporated - XLV: Healthcare

### Executive Summary

VALUE thesis: PEG 1.35 indicates fundamental undervaluation. Quality metrics strong (ROE 18%).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($304.78)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Axa S.A. Sells 155,294 Shares of UnitedHealth Group Incorporated $UNH**
- Source: MarketBeat | 20251209T083459 | Neutral | Relevance: 100%
-  Axa S.A. has reduced its stake in UnitedHealth Group by 34.6%, selling 155,294 shares and now holding 293,176 shares valued at $91.46 million. Despite this, institutional ownership remains high at 87.86%, with other major investors like Norges Bank and Dodge & Cox significantly increasing their positions. UnitedHealth Group reported strong Q3 earnings, beating EPS estimates, and announced a quarterly dividend of $2.21, reflecting a 2.7% yield.

**2. UnitedHealth Group Stock (UNH) Opinions on DOJ Investigation and Analyst Upgrades**
- Source: Quiver Quantitative | 20251206T173400 | Neutral | Relevance: 99%
-  Discussions about UnitedHealth Group (UNH) on X are divided between investor concern over a DOJ investigation into Medicare billing practices and cautious optimism following recent analyst upgrades. The article details insider trading activity, UNH's Q3 2025 revenues, Congressional stock trading, hedge fund activity, government contracts awarded to UNH, and recent analyst ratings and price targets.

**3. Can UNH's AI-Powered Virtual Assistance Enhance Member Experience?**
- Source: TradingView | 20251208T160808 | Neutral | Relevance: 99%
-  UnitedHealth Group (UNH) is integrating AI-powered virtual assistance to improve member experience by streamlining benefit navigation and healthcare choices. This initiative aims to automate routine tasks like checking claim status and finding in-network doctors, reducing call-center load and enhancing digital engagement. Competitors like Elevance Health and Humana are also expanding their AI healthcare solutions to offer more intuitive and personalized member interactions.

**4. UnitedHealth Group Incorporated $UNH Shares Sold by Fayez Sarofim & Co**
- Source: MarketBeat | 20251209T102446 | Neutral | Relevance: 98%
-  Fayez Sarofim & Co reduced its stake in UnitedHealth Group Incorporated by 4.1% in the second quarter, selling 47,778 shares but still owning 1,115,813 shares worth $350.12 million. Despite this, other institutional investors increased their holdings, and analysts maintain a "Hold" consensus rating with a target price of $385.54 for UNH, which recently declared a quarterly dividend of $2.21 per share.

**5. Stenger Family Office LLC Acquires Shares of 17,546 UnitedHealth Group Incorporated $UNH**
- Source: MarketBeat | 20251206T131034 | Somewhat-Bullish | Relevance: 98%
-  Stenger Family Office LLC recently purchased 17,546 shares of UnitedHealth Group (UNH), valued at approximately $5.47 million, making it their 16th largest holding. UnitedHealth Group surpassed Q3 earnings estimates with an EPS of $2.92 and reported revenue of $113.16 billion, an increase of 12.2% year-over-year. The company also declared a quarterly dividend of $2.21 per share, offering an annualized yield of 2.7%.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 23 ($0.00M) |
| Sells | 1 ($0.01M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 10.0% (-0.3%)
- Blackrock Inc.: 8.2% (-1.4%)
- State Street Corpora: 4.9% (-1.8%)
- JPMORGAN CHASE & CO: 4.1% (+85.6%)
- Geode Capital Manage: 2.4% (+2.2%)

### Key Risks

1. Long-term trend broken: trading 10.4% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.35 suggests fair value with growth premium. Forward P/E 18.3x stretched relative to 9% growth. Balance sheet: $5.1B free cash flow. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $293.1B |
| Beta | 0.43 |
| 52W Range | $234.60 - $606.36 |
| Short Interest | 1.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.35 |
| Forward P/E | 18.3 |
| Current P/E | 19.8 |
| YoY Growth | 8.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 weakening modestly (-0.9% over 5 days). Below STRENGTH zone by 6.4pp (needs >4.0% for momentum thesis). Below SMA200 (0.90x), long-term trend not supportive. MACD histogram positive (1.71), confirming momentum. RSI neutral at 45.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.39% (CS: 37) | Weak |
| RSI_14 | 45.2 | Neutral |
| MACD Histogram | 1.71 | Bullish |
| vs SMA20 | 0.996x | Below |
| vs SMA50 | 0.947x | Below |
| vs SMA200 | 0.896x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $323.62
- **Stop Loss:** $304.78 (5.8% risk)
- **Target:** $361.30 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 26
- **Position Value:** $8,414.12
- **Portfolio %:** 8.41%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-01-15 (Est: $2.10)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.81 | $2.92 | +4.0% |
| 2025Q2 | $4.45 | $4.08 | -8.2% |
| 2025Q1 | $7.29 | $7.20 | -1.3% |
| 2024Q4 | $6.74 | $6.81 | +1.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*